NCT05535309View on ClinicalTrials.gov

Establishment of Risk Factors Model of Drug-induced Coagulation Disorder Caused by Cefoperazone Sulbactam Sodium

CompletedOBSERVATIONAL
Enrollment

8,000

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

May 30, 2023

Study Completion Date

December 30, 2023

Conditions
Risk Factors
Interventions
DRUG

cefoperazone sulbactam sodium

Cefoperazone sodium and Sulbactam Sodium for injection (1; 1) are white or almost white powder drugs, and the components are cefoperazone sodium and sulbactam sodium

Trial Locations (1)

Unknown

Xiao Li,MD, Jinan

All Listed Sponsors
lead

Qianfoshan Hospital

OTHER

NCT05535309 - Establishment of Risk Factors Model of Drug-induced Coagulation Disorder Caused by Cefoperazone Sulbactam Sodium | Biotech Hunter | Biotech Hunter